English  |  正體中文  |  简体中文  |  总笔数 :2856600  
造访人次 :  53471325    在线人数 :  969
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

"_"的相关文件

回到依作者浏览
依题名排序 依日期排序

显示项目 836-845 / 4992 (共500页)
<< < 79 80 81 82 83 84 85 86 87 88 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
國立成功大學 2024-06 Estimation of natural convection heat transfer characteristics of rack server in a cavity: experimental and numerical analyzes Chen;Han-Taw;Chen;Kuan-Xun;Amani;Mohammad;Rysavy;J;Yan;Wei-Mon
國立成功大學 2024-06 Evidence of the γ-ray counterpart of nova FM Cir from Fermi-LAT Wang;H, H. H.;Yan;H, D.;Lin;L, C. -C.;Takata;J;Tam;P, -H. T.
國立成功大學 2024-06 Vibostolimab coformulated with pembrolizumab (vibo/ pembro) plus chemotherapy (chemo) as first-line treatment for advanced esophageal cancer (ec): Results from cohort E of the phase II KEYVIBE-005 study Hsu;C-H;Dziadziuszko;R;Abreo, Gomez;D, A.;Aksoy;S;Martin, Gil;M;Roderburg;C;Yen;C, J.;Arican;A;Cassier;P;Im;S-A;Kim;S-B;Kudo;T;Ochsenreither;S;Sendur;M, A. N.;Yonemori;K;Rojas;C, I.;Liu;Q;Keenan;T;Healy;J;Kwiatkowski;M
國立成功大學 2024-06 Vibostolimab coformulated with pembrolizumab (vibo/ pembro) plus chemotherapy (chemo) as first-line treatment for advanced esophageal cancer (ec): Results from cohort E of the phase II KEYVIBE-005 study Hsu;C-H;Dziadziuszko;R;Abreo, Gomez;D, A.;Aksoy;S;Martin, Gil;M;Roderburg;C;Yen;C, J.;Arican;A;Cassier;P;Im;S-A;Kim;S-B;Kudo;T;Ochsenreither;S;Sendur;M, A. N.;Yonemori;K;Rojas;C, I.;Liu;Q;Keenan;T;Healy;J;Kwiatkowski;M
國立成功大學 2024-06 Recovery of Lithium from Industrial Li-Containing Wastewater Using Fluidized-Bed Homogeneous Granulation Technology Le;Giang, Van;Luu;Anh, The;Tran;Tuan, Huu;Bui;Ngoc, T.;Mofijur;M;Nguyen;Ky, Minh;Bui;Thanh, Xuan;Bahari;M, B.;Vo;Phong, Hoang Nhat;Vu;Thanh, Chi;Chien;Chang, Guo-Ping;Huang;Yao-Hui
國立成功大學 2024-06 Vibostolimab coformulated with pembrolizumab (vibo/ pembro) plus chemotherapy (chemo) as first-line treatment for advanced esophageal cancer (ec): Results from cohort E of the phase II KEYVIBE-005 study Hsu;C-H;Dziadziuszko;R;Abreo, Gomez;D, A.;Aksoy;S;Martin, Gil;M;Roderburg;C;Yen;C, J.;Arican;A;Cassier;P;Im;S-A;Kim;S-B;Kudo;T;Ochsenreither;S;Sendur;M, A. N.;Yonemori;K;Rojas;C, I.;Liu;Q;Keenan;T;Healy;J;Kwiatkowski;M
國立成功大學 2024-06 An inverse method of fundamental solutions for the identification of 2D elastic properties of anisotropic solids Hematiyan;M, R.;Khosravifard;A;Mohammadi;M;Shiah;Y, C.
國立成功大學 2024-06 Investigating the protective role of CD44 and microRNA-146a in tendinopathic tenocytes: a signaling axis regulating apoptosis Chen;S;Wu;P
國立成功大學 2024-06 Vibostolimab coformulated with pembrolizumab (vibo/ pembro) plus chemotherapy (chemo) as first-line treatment for advanced esophageal cancer (ec): Results from cohort E of the phase II KEYVIBE-005 study Hsu;C-H;Dziadziuszko;R;Abreo, Gomez;D, A.;Aksoy;S;Martin, Gil;M;Roderburg;C;Yen;C, J.;Arican;A;Cassier;P;Im;S-A;Kim;S-B;Kudo;T;Ochsenreither;S;Sendur;M, A. N.;Yonemori;K;Rojas;C, I.;Liu;Q;Keenan;T;Healy;J;Kwiatkowski;M
國立成功大學 2024-06 Vibostolimab coformulated with pembrolizumab (vibo/ pembro) plus chemotherapy (chemo) as first-line treatment for advanced esophageal cancer (ec): Results from cohort E of the phase II KEYVIBE-005 study Hsu;C-H;Dziadziuszko;R;Abreo, Gomez;D, A.;Aksoy;S;Martin, Gil;M;Roderburg;C;Yen;C, J.;Arican;A;Cassier;P;Im;S-A;Kim;S-B;Kudo;T;Ochsenreither;S;Sendur;M, A. N.;Yonemori;K;Rojas;C, I.;Liu;Q;Keenan;T;Healy;J;Kwiatkowski;M

显示项目 836-845 / 4992 (共500页)
<< < 79 80 81 82 83 84 85 86 87 88 > >>
每页显示[10|25|50]项目